Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial.
Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial. Ann Clin Transl Neurol. 2021 03; 8(3):711-715.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal, Humanized
Female
Follow-Up Studies
Humans
Immunologic Factors
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting
authors with profiles
Gabriel Pardo